EXASOL AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.45 EUR | +0.41% |
|
+1.24% | -22.10% |
| Feb. 21 | Exasol Unveils New Suite of AI Tools to Turbocharge Enterprise Data Analytics | CI |
| Feb. 21 | Transcript : Exasol AG, 2023 Earnings Call, Feb 21, 2024 |
Strengths
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Business Support Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -22.10% | 69.53M | - | ||
| +5.21% | 4.03B | D+ | ||
| +20.98% | 1.89B | B- | ||
| +3.13% | 1.63B | - | B- | |
| -3.22% | 1.71B | - | ||
| -16.98% | 1.58B | D- | ||
| -23.29% | 1.36B | - | ||
| -7.67% | 1.16B | - | ||
| -4.66% | 1.05B | - | - | |
| +119.33% | 694M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- EXL Stock
- Ratings Exasol AG
